Inhibition of influenza virus hemagglutinin-mediated membrane fusion by a compound related to podocarpic acid

Virology

Volumn 248, Issue 2, 1998, Pages 264-274

  Staschke, K A ^a   Hatch, S D ^a   Tang, J C ^a   Hornback, W J ^a   Munroe, J E ^a   Colacino, J M ^a   Muesing, M A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMAGGLUTININ; PODOCARPIC ACID DERIVATIVE;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONFORMATIONAL TRANSITION; DISULFIDE BOND; INFLUENZA VIRUS; INTERNALIZATION; MEMBRANE FUSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; PROTEIN SYNTHESIS REGULATION; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS RESISTANCE;

ANIMALIA; INFLUENZA VIRUS; RNA VIRUSES;

EID: 0032169618     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9273     Document Type: Article

References (38)

1. Bodian D. L., Yamasaki B. R., Buswell R. L., Stearns J. F., White J. M., Kuntz I. D. Inhibition of the fusion-inducing conformational change of influenza hemagglutinin by benzoquinones and hydroquinones. Biochemistry. 32:1993;2967-2978.
2. Bullough P. A., Hughson F. M., Skehel J. J., Wiley D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 371:1994;37-43.
3. Carr C. M, Kim P. S. A spring-loaded mechanism for the conformational change of influenza hemagglutinin. Cell. 73:1993;823-832.
4. Carson M. Ribbon models of macromolecules. J. Mol. Graphics. 5:1987;103-106.
5. Daniels R. S., Downie J. C., Hay A. J., Knossow M., Skehel J. J., Wang M. L., Wiley D. C. Fusion mutants of the influenza virus hemagglutinin glycoprotein. Cell. 40:1985;431-439.
6. Guinea R., Carrasco L. Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells. J. Virol. 69:1995;2306-2312.
7. Hay A. J. The action of adamantanamines against influenza A viruses: inhibition of the M2 ion channel protein. Semin. Virol. 3:1992;21-30.
8. Hay A. J., Wolstenholme A. J., Skehel J. J., Smith M. H. The molecular basis of the specific anti-influenza action of amantadine. EMBO J. 4:1985;3021-3024.
9. Hayden F. G., Cote K. M., Douglas R. G. Jr. Plaque inhibition assay for drug susceptibility testing of influenza viruses. Antimicrob. Agents Chemother. 17:1980;865-870.
10. Hoffman L. R., Kuntz I. D., White J. M. Structure-based identification of an inducer of the low-pH conformational change in the influenza virus hemagglutinin: irreversible inhibition of infectivity. J. Virol. 71:1997;8808-8820.
11. Huang R. T. C., Rott R., Klenk H. D. Influenza viruses cause hemolysis and fusion of cells. Virology. 110:1981;243-247.
12. Kanaseki T., Kawasaki K., Murata M., Ikeuchi Y., Ohnishi S. Structural features of membrane fusion between influenza virus and liposome as revealed by quick-freezing electron microscopy. J. Cell Biol. 137:1997;1041-1056.
13. Klenk H.-D., Rott R., Orlich M., Blodorn J. Activation of influenza viruses by trypsin treatment. Virology. 68:1975;426-439.
14. Lazarowitz S. G., Choppin P. W. Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the haemagglutinin polypeptide. Virology. 68:1975;440-454.
15. Luo G., Colonno R., Krystal M. Characterization of a hemagglutinin-specific inhibitor of influenza A virus. Virology. 226:1996;66-76.
16. Luo G., Torri A., Harte W. E., Danetz S., Cianci C., Tiley L., Day S., Mullaney D., Yu K. L., Ouellet C., Dextraze P., Meanwell N., Colonno R., Krystal M. Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus. J. Virol. 71:1997;4062-4070.
17. Maeda T., Ohnishi S. I. Activation of influenza viruses by acidic media causes hemolysis and fusion of erythrocytes. FEBS Lett. 122:1980;283-287.
18. Maeda T., Kawasaki K., Ohnishi S. Interaction of influenza virus hemagglutinin with target membrane lipids is a key step in virus-induced hemolysis and fusion at pH 5. 2. Proc. Natl. Acad. Sci. USA. 78:1981;4133-4137.
19. Matlin K. S., Reggio H., Helenius A., Simons K. Infectious entry pathway of influenza virus in a canine kidney cell line. J. Cell Biol. 91:1981;601-613.
20. Ott S., Wunderli-Allenspach H. Effect of virostatic norakin (triperiden) on influenza virus activities. Antiviral Res. 24:1994;37-42.
21. Parish E. J., Miles D. H. Investigation of the antitumor activity of podocarpic acid derivatives. J. Pharm. Sci. 73:1984;694-696.
22. Presber H. W., Schroeder C., Hegenscheid B., Heider H., Reefschlager J., Rosenthal H. A. Antiviral activity of norakin (triperiden) and related anticholinergic antiparkinsonism drugs. Acta Virol. 28:1984;501-507.
23. Prosch S., Heider H., Schroeder C., Kruger D. H. Mutations in the hemagglutinin gene associated with influenza virus resistance to norakin. Arch. Virol. 102:1988;125-129.
24. Prosch S., Heider H., Schroeder C., Shilov A. A., Sinitzyn B. V., Blinov V. M., Kruger D. H., Frommel C. Mapping mutations in influenza A virus resistant to norakin. FEBS Lett. 267:1990;19-21.
25. Reed L. J., Muench H. A simple method of estimating fifty per cent endpoints. Am. J. Hyg. 27:1938;493-497.
26. Sato S. B., Kawasaki K., Ohnishi S. Hemolytic activity of influenza virus hemagglutinin glycoproteins activated in mildly acidic environments. Proc. Natl. Acad. Sci. USA. 80:1983;3153-3157.
27. Skehel J. J., Bayley P. M., Brown E. B., Martin S. R., Waterfield M. D., White J. M., Wilson I. A., Wiley D. C. Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc. Natl. Acad. Sci. USA. 79:1982;968-972.
28. von Itzstein M., Jin B., Wu W.-Y., Chandler M. A convenient method for the introduction of nitrogen and sulfur at the C-4 of a sialic acid analog. Carbohydr. Res. 224:1993;181-185.
29. von Itzstein M., Wu W.-Y., Jin B. The synthesis of 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N. Carbohydr. Res. 259:1994;301-305.
30. Weber T., Paesold G., Galli C., Mischler R., Semenza G., Brunner J. Evidence for H(+)-induced insertion of influenza hemagglutinin HA2 N-terminal segment into viral membrane. J. Biol. Chem. 269:1994;18353-18358.
31. Weis W. I., Cusack S. C., Brown J. H., Daniels R. S., Skehel J. J., Wiley D. C. The Structure of a membrane fusion mutant of the influenza virus haemagglutinin. EMBO J. 9:1990;17-24.
32. Wharton S. A., Calder L. J., Ruigrok R. W., Skehel J. J., Steinhauer D. A., Wiley D. C. Electron microscopy of antibody complexes of influenza virus haemagglutinin in the fusion pH conformation. EMBO J. 14:1995;240-246.
33. White J. M. Viral, and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:1990;675-697.
34. White J., Matlin K., Helenius A. Cell fusion by Semliki forest, influenza, and vesicular stomatitis virus. J. Cell Biol. 89:1981;674-679.
35. White J., Kartenbeck J., Helenius A. Membrane fusion activity of influenza virus. EMBO J. 1:1982;217-222.
36. Wiley D. C., Skehel J. J. The structure and function of the hemagglutinin membrane glycoprotein of influenza virus. Annu. Rev. Biochem. 56:1987;365-374.
37. Wilson I. A., Skehel J. J., Wiley D. C. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 D resolution. Nature. 289:1981;373-378.
38. Yoshimura A., Kuroda K., Kawasaki K., Yamashina S., Maeda T., Ohnishi S. Infectious cell entry mechanism of influenza virus. J. Virol. 43:1982;284-293.